GlaxoSmithKline Plans Adjustments To Its Sales Incentive Program
GlaxoSmithKline’s 2012 Corporate Integrity Agreement made mandatory the company’s “Patient First” program (or a…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
April 2015
Doctor’s Article Counters The “Myths That Undermine Medical…
Thomas Stossel, American Cancer Society Professor of Medicine at Harvard Medical School and a visiting scholar at the American…
FDA Finalizes Two Guidances To Speed Approvals For Innovative Medical…
The Food and Drug Administration last week finalized two guidances intended to speed the process of getting innovative…
CME: Online Medical Education Could Revolutionize Training in Emerging…
A recent article published in Forbes argues that online medical education has the opportunity to revolutionize training…
Open Payments Issues For Physicians To Watch For In The Dispute Resolution…
To comply with the Physician Payments Sunshine Act, drug and medical device manufacturers submitted their 2014 Open Payments…
LIFE SCIENCE COMPLIANCE UPDATE
This month we are launching our newest publication, Life Science Compliance Update. This publication promises to deliver…
CMS and OIG Discuss “The Use of Data to Stop Medicare Fraud” Before House…
The House Ways and Means Subcommittee on Oversight recently held a hearing on the federal government’s use of data analysis to…
DOJ Targets Physicians For Accepting Bribes In Exchange For Referrals
Last week we posted a comprehensive look at the increased scrutiny into laboratories that engage in referrals with…
Arnold & Porter US and EU Drug and Device Enforcement Boot Camp
Arnold & Porter is hosting a full-day, interactive program aimed at providing industry professionals with unique real world…
Public Citizen Urges FDA To Penalize Drug Makers Over Diabetes Ads,…
Consumer advocacy group Public Citizen is calling on the Food and Drug Administration (FDA) to “stop the apparently violative…